{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:59:50Z","timestamp":1753891190822,"version":"3.41.2"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Design<\/jats:title><jats:p>Prospective, double-blind clinical trial comparing tetanus-diphtheria vaccine administration routes, intramuscular (IM) vs. subcutaneous (SC) injection, in patients with oral anticoagulants. ISRCTN69942081.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study population<\/jats:title><jats:p>Patients treated with oral anticoagulants, 15 health centers, Vigo (Spain). Sample size, 117 in each group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcome variables<\/jats:title><jats:p>Safety analysis: systemic reactions and, at the vaccine administration site, erythematic, swelling, hematoma, granuloma, pain.<\/jats:p><jats:p>Effectiveness analysis: differences in tetanus toxoid antibody titers.<\/jats:p><jats:p>Independent variables: route, sex, age, baseline serology, number of doses administered.<\/jats:p><\/jats:sec><jats:sec><jats:title>Analysis<\/jats:title><jats:p>Following the CONSORT guidelines, we performed an intention-to-treat analysis. We conducted a descriptive study of the variables included in both groups (117 in each group) and a bivariate analysis. Fewer than 5% of missing values. Imputation in baseline and final serology with the median was performed. Lost values were assumed to be values missing at random. We conducted a descriptive study of the variables and compared routes. For safety, multivariate logistic regression was applied, with each safety criterion as outcome and the independent variables. Odds ratios (ORs) were calculated. For effectiveness, a generalized additive mixed model, with the difference between final and initial antibody titers as outcome. Due to the bimodal distribution of the outcome, the normal mixture fitting with gamlssMX was used. All statistical analyses were performed with the gamlss.mx and texreg packages of the R free software environment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A previously published protocol was used across the 6-year study period. The breakdown by sex and route showed: 102 women and 132 men; and 117 IM and 117 SC, with one dose administered in over 80% of participants. There were no differences between groups in any independent variable. The second and third doses administered were not analyzed, due to the low number of cases. In terms of safety, there were no severe general reactions. Locally, significant adjusted differences were observed: in pain, by sex (male, OR: 0.39) and route (SC, OR: 0.55); in erythema, by sex (male, OR: 0.34) and route (SC, OR: 5.21); and in swelling, by sex (male, OR: 0.37) and route (SC, OR: 2.75). In terms of effectiveness, the model selected was the one adjusted for baseline serology.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1054988","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T08:49:45Z","timestamp":1671698985000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and safety of tetanus vaccine administration by intramuscular vs. subcutaneous route in anticoagulated patients: Randomized clinical trial in primary care"],"prefix":"10.3389","volume":"9","author":[{"given":"Fernando Isidro","family":"Lago-Deibe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Valladares-Cabaleiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Fern\u00e1ndez-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Fern\u00e1ndez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Claver\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Rodr\u00edguez-Pastoriza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Roca-Pardinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Victoria","family":"Mart\u00edn-Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"journal-title":"Epidemiolog\u00eda del t\u00e9tanos en Espa\u00f1a, 2005-2015","year":"2017","key":"B1"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(18)33131-3","article-title":"Tetanus","volume":"393","author":"Yen","year":"2019","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.aprim.2020.08.001","article-title":"Prevenci\u00f3n de las enfermedades infecciosas. Actualizaci\u00f3n en vacunas 2020","volume":"52","author":"Schwarz Chavarri","year":"2020","journal-title":"Aten Primaria"},{"journal-title":"2 \u00b0 Estudio de Seroprevalencia en Espana~","year":"2020","key":"B4"},{"key":"B5","first-page":"571","article-title":"Inmunidad frente al t\u00e9tanos en adultos mayores de 49 a\u00f1os","volume":"103","author":"Cilla","year":"1994","journal-title":"Med Clin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1016\/j.vaccine.2005.01.085","article-title":"Insufficient protection for healthy elderly adults by tetanus and TBE vaccines","volume":"23","author":"Hainz","year":"2005","journal-title":"Vaccine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.medcli.2012.12.023","article-title":"Caracter\u00edsticas de los pacientes y abordaje terap\u00e9utico de la fibrilaci\u00f3n auricular en atenci\u00f3n primaria: estudio FIATE","volume":"141","author":"Lobos-Bejarano","year":"2013","journal-title":"Med Clin"},{"key":"B8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3122\/jabfm.18.1.20","article-title":"Missed opportunities to vaccinate older adults in primary care","volume":"18","author":"Nowalk","year":"2005","journal-title":"J Am Board Fam Pract"},{"key":"B9","first-page":"1","article-title":"Preventing Tetanus, Diphtheria and Pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Recommendations for the Advisoy Committee on inmunization Practices","volume":"55","year":"2006","journal-title":"MMWR"},{"key":"B10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1055\/s-2007-994804","article-title":"Delayed lumbar spinal hematoma. Discussion of the risk factors: hypertensi\u00f3n, anticoagulation and spinal anesthesia","volume":"33","author":"Wildfoster","year":"1998","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1136\/bmj.322.7282.364","article-title":"Importance of injecting vaccines into muscle. Parenteral vaccines must be given subcutaneously in patients with congenital bleeding disorders","volume":"322","author":"Seale","year":"2001","journal-title":"BMJ"},{"journal-title":"Recomendaciones de utilizaci\u00f3n de vacunas Td","year":"","key":"B12"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1136\/bmj.321.7271.1237","article-title":"The importance of injecting vaccines into muscle","volume":"321","author":"Zuckerman","year":"2000","journal-title":"BMJ"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1080\/21645515.2020.1814094","article-title":"Subcutaneous vaccine administration - an outmoded practice","volume":"17","author":"Cook","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/S0264-410X(98)00410-1","article-title":"Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents","volume":"17","author":"Mark","year":"1999","journal-title":"Vaccine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/BF00144763","article-title":"Immune response to hepatitis B vaccine given at different injection sites and by different routes: a controlled randomized study","volume":"4","author":"de Lalla","year":"1988","journal-title":"Eur J Epidemiol"},{"volume-title":"Manual de vigilancia de eventos supuestamente atribuibles a la vacunaci\u00f3n o inmunizaci\u00f3n en la Regi\u00f3n de las Am\u00e9ricas","year":"2021","key":"B17"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e91366","DOI":"10.1371\/journal.pone.0091366","article-title":"Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (IM), subcutaneous (SC) and intradermal (ID) administration (VRC 011)","volume":"9","author":"Enama","year":"2014","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e646","DOI":"10.1542\/peds.2007-1653","article-title":"Prospective assessment of the effect of needle length and injection site on the risk of local reaction to the fifth diphtheria-tetanus-acellular pertussis vaccination","volume":"121","author":"Jackson","year":"2008","journal-title":"Pediatrics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/bmj.38906.704549.7C","article-title":"Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomized, controlled trial","volume":"333","author":"Diggle","year":"2006","journal-title":"BMJ"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1136\/bmj.300.6741.1694-a","article-title":"Safety of intramuscular injections of hepatitis B vaccine in haemofiliacs","volume":"300","author":"Evans","year":"1990","journal-title":"BMJ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1157\/13072321","article-title":"Utilizaci\u00f3n de la v\u00eda intramuscular para la administraci\u00f3n de la vacuna antigripal en pacientes que reciben anticoagulantes orales","volume":"124","author":"Ballester","year":"2005","journal-title":"Med Clin"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2326-8-1","article-title":"Safety of intramuscular influenza vaccine in patients receiving oral anticoagulation therapy: a single blinded multi-centre randomized controlled clinical trial","volume":"8","author":"Casajuana","year":"2008","journal-title":"BMC Blood Disord"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e2035693","DOI":"10.1001\/jamanetworkopen.2020.35693","article-title":"Immunogenicity and safety of reduced-dose intradermal vs intramuscular influenza vaccines a systematic review and meta-analysis","volume":"4","author":"Egunsola","year":"2021","journal-title":"JAMA Newt Open"},{"key":"B25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1471-2296-15-147","article-title":"The safety and efficacy of the tetanus vaccine intramuscularly versus subcutaneously in anticoagulated patients: a randomized clinical trial","volume":"15","author":"Lago-Deibe","year":"2014","journal-title":"BMC Fam Pract"},{"key":"B26","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"key":"B27","unstructured":"MadridMinisterio de Sanidad y Consumo2008"},{"key":"B28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s40629-016-0006-7","article-title":"Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC)","volume":"26","author":"Klimek","year":"2017","journal-title":"Allergo J Int"},{"key":"B29","unstructured":"NEWS for R version 4.1.32022"},{"key":"B30","unstructured":"The R Stats Package-R"},{"key":"B31","unstructured":"StasinopoulosM RigbyB Package gamlss.mx2005"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1586\/14760584.2015.1081067","article-title":"Effect of vaccine administration modality on immunogenicity and efficacy","volume":"14","author":"Zhang","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"B33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1542\/peds.97.2.236","article-title":"Comparison of diphtheria-tetanus-two component acellular pertussis vaccines in United States and Japanese infants at 2, 4, and 6 months of age","volume":"97","author":"Rothstein","year":"1996","journal-title":"Pediatrics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.intimp.2013.12.023","article-title":"Are the anatomical sites for vaccine administration selected judiciously?","volume":"19","author":"Malik","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1016\/j.vaccine.2012.02.068","article-title":"Effect of needle length for response to hepatitis B vaccine in macrosomic neonates: a prospective randomized study","volume":"30","author":"Ozdemir","year":"2012","journal-title":"Vaccine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1542\/peds.2009-1592","article-title":"Effect of needle length when immunizing obese adolescents with hepatitis B vaccine","volume":"125","author":"Middleman","year":"2010","journal-title":"Pediatrics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4161\/hv.4.3.5318","article-title":"Novel vaccines and adjuvant systems: the utility of animal models for predicting immunogenicity in humans","volume":"4","author":"Davis","year":"2008","journal-title":"Hum Vaccine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e106629","DOI":"10.1371\/journal.pone.0106629","article-title":"The effect of prophylactic antipyretic administration on post-vaccination adverse reactions and antibody response in children: a systematic review","volume":"9","author":"Das","year":"2014","journal-title":"PLoS ONE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/j.vaccine.2017.02.035","article-title":"A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations","volume":"35","author":"Wysocki","year":"2017","journal-title":"Vaccine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/infdis\/jiv456","article-title":"Influence of statins on influenza vaccine response in elderly individuals","volume":"213","author":"Black","year":"2016","journal-title":"J Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1017\/S095026880100629X","article-title":"Immunogenicity and reactogenicity of the adult tetanus-diphtheria vaccine. How many doses are necessary?","volume":"127","author":"Bayas","year":"2001","journal-title":"Epidemiol Infect"},{"key":"B42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1131-3587(16)30016-4","article-title":"Acceso a los anticoagulantes de acci\u00f3n directa en Espa\u00f1a","volume":"16","author":"Seg\u00fa","year":"2016","journal-title":"Rev Esp Cardiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1056\/NEJM199503233321201","article-title":"A population-based serologic survey of immunity to tetanus in the United States","volume":"332","author":"Gergen","year":"1995","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/sj.gene.6364051","article-title":"Genetic regulation of immune responses to vaccines in early life","volume":"5","author":"Newport","year":"2004","journal-title":"Genes Immun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e00084","DOI":"10.1128\/CMR.00084-18","article-title":"Factors that influence the immune response to vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1542\/peds.83.5.679","article-title":"Adverse reactions to diphtheria, tetanus, pertussis-polio vaccination at 18 months of age: effect of injection site and needle length","volume":"83","author":"Ipp","year":"1989","journal-title":"Pediatrics"},{"key":"B47","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/j.1875-9114.1998.tb03127.x","article-title":"Influenza vaccination and warfarin anticoagulation: a comparison of subcutaneous and intramuscular routes of administration in elderly men","volume":"18","author":"Delafuente","year":"1998","journal-title":"Pharmacotherapy"},{"key":"B48","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1134-2072(03)75907-6","article-title":"Control del tratamiento anticoagulante oral: \u2018en atenci\u00f3n primaria o en servicios de hematolog\u00eda?","volume":"10","author":"Mestre Gallinata","year":"2003","journal-title":"FMC"},{"key":"B49","first-page":"127","article-title":"Situaci\u00f3n actual del control de la anticoagulaci\u00f3n oral en atenci\u00f3n primaria","volume":"24","author":"Alonso Roca","year":"1999","journal-title":"Aten Primaria"},{"key":"B50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.aprim.2012.09.003","article-title":"Dificultades de selecci\u00f3n en los ensayos cl\u00ednicos en atenci\u00f3n primaria. Cuando no se llega al tama\u00f1o muestral","volume":"45","author":"Llor","year":"2013","journal-title":"Aten Primaria"},{"key":"B51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0212-6567(02)70513-1","article-title":"\u2018Por qu\u00e9 tan pocos ensayos cl\u00ednicos en atenci\u00f3n primaria?","volume":"29","author":"Grandes","year":"2002","journal-title":"Aten Primaria"},{"key":"B52","unstructured":"Agencia Espanola de Medicamentos y Productos Sanitarios. Informe de posicionamiento terap\u00e9utico UT\/V5\/21112016. Criterios y recomendaciones generales para el uso de los anticoagulantes orales directos (ACOD) en la prevenci\u00f3n del ictus y la embolia sist\u00e9mica en pacientes con fibrilaci\u00f3n auricular no valvular~2016"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1054988\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T11:45:49Z","timestamp":1701603949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1054988\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":52,"alternative-id":["10.3389\/fmed.2022.1054988"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1054988","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"article-number":"1054988"}}